trial · primary record
Experimental drug (paracetamol 500mg / fexofenadine 60mg / phenylephrine 20mg)
Cold
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 567 |
| Primary completion | 2025-08-26 |
| Primary endpoint | Relief of cold and flu symptoms |
| Registry ID | NCT05118672 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:39.498Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05118672
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.